Evolving Personalized Therapy for Castration-Resistant Prostate Cancer

With advances in molecular biologic and genomic technology, detailed molecular mechanisms for development of castration-resistant prostate cancer (CRPC) have surfaced. Metastatic prostate cancer (PCa) no longer represents an end stage, with many emerging therapeutic agents approved as effective in p...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Biomedicine (Taipei)
Prif Awduron: Liu, Hsin-Ho, Tsai, Yuh-Shyan, Lai, Chen-Li, Tang, Chih-Hsin, Lai, Chih-Ho, Wu, Hsi-Chin, Hsieh, Jer-Tsong, Yang, Che-Rei
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: China Medical University 2014
Pynciau:
Review Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC4264971/
https://ncbi.nlm.nih.gov/pubmed/25520915
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7603/s40681-014-0002-5
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg